Fig. 4From: Combination therapy of human bone marrow–derived mesenchymal stem cells and minocycline improves neuronal function in a rat middle cerebral artery occlusion modelVolume of infarcted area. a Coronally sectioned brain tissue at a level of 10 mm from bregma with triphenyl tetrazolium chloride stain. b Quantitative analysis of infarction volume. The combination therapy group showed significantly lower infarction volume compared with other groups. Kruskal–Wallis test. *P <0.01. Abbreviation: hBM-MSC human bone marrow–derived mesenchymal stem cellBack to article page